The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Definitive Healthcare Corp (NASDAQ: DH) closed at $4.35 up 0.69% from its previous closing price of $4.32. In other words, the price has increased by $0.69 from its previous closing price. On the day, 0.52 million shares were traded. DH stock price reached its highest trading level at $4.4 during the session, while it also had its lowest trading level at $4.21.
Ratios:
For a deeper understanding of Definitive Healthcare Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.78. For the most recent quarter (mrq), Quick Ratio is recorded 2.31 and its Current Ratio is at 2.31. In the meantime, Its Debt-to-Equity ratio is 0.40 whereas as Long-Term Debt/Eq ratio is at 0.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on September 17, 2024, initiated with a Buy rating and assigned the stock a target price of $7.
On July 31, 2024, JP Morgan Downgraded its rating to Underweight which previously was Neutral and also lowered its target price recommendation from $7 to $5.
Morgan Stanley Downgraded its Overweight to Equal-Weight on May 08, 2024, whereas the target price for the stock was revised from $11.50 to $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DH now has a Market Capitalization of 509485024 and an Enterprise Value of 711787520. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.97 while its Price-to-Book (P/B) ratio in mrq is 0.79. Its current Enterprise Value per Revenue stands at 2.754 whereas that against EBITDA is 25.507.
Stock Price History:
Over the past 52 weeks, DH has reached a high of $10.62, while it has fallen to a 52-week low of $3.19. The 50-Day Moving Average of the stock is -5.60%, while the 200-Day Moving Average is calculated to be -36.59%.
Shares Statistics:
For the past three months, DH has traded an average of 962.58K shares per day and 521550 over the past ten days. A total of 116.56M shares are outstanding, with a floating share count of 47.10M. Insiders hold about 59.79% of the company’s shares, while institutions hold 42.67% stake in the company. Shares short for DH as of 1724976000 were 2886158 with a Short Ratio of 3.00, compared to 1722384000 on 3412613. Therefore, it implies a Short% of Shares Outstanding of 2886158 and a Short% of Float of 5.38.